Garamycin and Zofran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Garamycin (gentamicin sulfate) and Zofran (ondansetron hydrochloride). Common drug interactions include coronary artery disease among females and acute respiratory distress syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Garamycin and Zofran. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Garamycin?

Garamycin has active ingredients of gentamicin sulfate. eHealthMe is studying from 440 Garamycin users. Check the latest studies of Garamycin.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.



On Jul, 18, 2026

27 people who take Garamycin and Zofran together, and have interactions are studied.

Garamycin and Zofran drug interactions.

What are the common drug interactions of Garamycin and Zofran, by gender? *:

female:

  1. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  2. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  3. Dementia (madness)
  4. Depression
  5. Dermatitis psoriasiform (large white or silver flakes on the skin)
  6. Disease progression
  7. Drug eruption (adverse drug reaction of the skin)
  8. Endocarditis staphylococcal (an inflammation of the inner layer of the heart by staphylococcal bacterial infection)
  9. Eye pruritus (eye itching)
  10. Fall

male:

  1. Acute respiratory distress syndrome
  2. Cardiac failure
  3. Anti-erythropoietin antibody positive
  4. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
  5. Asthenia (weakness)
  6. Blood disorder
  7. Chronic kidney disease
  8. Diarrhoea
  9. Drug ineffective
  10. General physical health deterioration (weak health status)

What are the common drug interactions of Garamycin and Zofran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Acute respiratory distress syndrome
  3. Cardiac failure
  4. Hepatocellular injury (liver injury)
  5. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  6. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Acute leukaemia (blood cancer)
  9. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  10. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)

10-19:

  1. Abdominal pain
  2. Cholecystitis (infection of gallbladder)
  3. Gallbladder disorder
  4. Anaemia postoperative
  5. Constipation
  6. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  7. Hypotension (abnormally low blood pressure)
  8. Hypoxia (low oxygen in tissues)
  9. Infusion related reaction
  10. Post lumbar puncture syndrome

20-29:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)

30-39:

  1. Anti-erythropoietin antibody positive
  2. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
  3. Asthenia (weakness)
  4. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  5. Cholecystitis (infection of gallbladder)
  6. Death
  7. Drug ineffective
  8. Gallbladder disorder
  9. Abdominal pain
  10. Anaemia (lack of blood)

40-49:

  1. Abscess limb (limb infection)
  2. Cellulitis (infection under the skin)
  3. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  4. Nerve injury
  5. Pain
  6. Perirectal abscess
  7. Rectal abscess (pus in rectum)
  8. Scar
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Acinetobacter bacteraemia (infection of bacteria)

50-59:

n/a

60+:

  1. Hypokalaemia (low potassium)
  2. Blood creatinine increased
  3. Pyrexia (fever)
  4. Suffocation feeling
  5. Weight decreased
  6. Abdominal discomfort
  7. Abdominal distension
  8. Abdominal pain
  9. Anaemia (lack of blood)
  10. Atelectasis (partial or complete collapse of the lung)

What are the existing conditions these people have? *

  1. Pain: 6 people, 22.22%
  2. Constipation: 6 people, 22.22%
  3. Birth Control: 5 people, 18.52%
  4. Acne (skin problems that cause pimples): 4 people, 14.81%
  5. Hypotension (abnormally low blood pressure): 4 people, 14.81%
  6. Stress And Anxiety: 3 people, 11.11%
  7. Premenstrual Syndrome: 3 people, 11.11%
  8. Nausea And Vomiting: 3 people, 11.11%
  9. Cough: 2 people, 7.41%
  10. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Garamycin and Zofran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Garamycin and Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Garamycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Garamycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate and ondansetron hydrochloride (the active ingredients of Garamycin and Zofran, respectively), and Garamycin and Zofran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: